Investment
Features
FeesSafety
Academy
More
Pluang+

Compare American Homes 4 Rent Class A (AMH) vs Boston Scientific Corporation (BSX) Price & Performance

American Homes 4 Rent Class A
Boston Scientific Corporation

Price performance

Price movement over the last 24 hours

Key statistics

American Homes 4 Rent Class A vs Boston Scientific Corporation — how do they compare? American Homes 4 Rent Class A trades at $33.27 (market cap $11.97B), while Boston Scientific Corporation trades at $45 (market cap $66.54B). The key difference: Boston Scientific Corporation is far larger — about 5.6× American Homes 4 Rent Class A's market cap, and American Homes 4 Rent Class A pays a 3.97% dividend while Boston Scientific Corporation pays none. Which is the better fit depends on your goals.

AMHBSX
Market Cap
$11.97B$66.54B
Sector
Real EstateHealth
52-Week High
$36.74$108.14
52-Week Low
$27.38$42.68
Enterprise Value
$17.05B$76.12B
Dividend Yield
3.97%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

American Homes 4 Rent Class A

AMH (American Homes 4 Rent) trades at $33.27, up 1.0% with a bullish technical signal and strong earnings momentum after beating estimates for three consecutive quarters. The company maintains robust fundamentals with 24.48% net income margin and $1.85B revenue in 2025, supported by 95% occupancy rates in the single-family rental market. Recent dividend declaration of $0.33 per share and positive analyst sentiment with 58% buy ratings reinforce strength.

Outlook remains positive given consistent operational performance and strategic focus on Sunbelt and Midwest markets. Key risks include high debt levels at $5.01B and sensitivity to interest rate changes. With consensus price target of $35.68 offering 7.2% upside, the stock presents a compelling opportunity for income and growth investors despite macroeconomic headwinds.

Boston Scientific Corporation

Boston Scientific (BSX) trades at $44.77, down 0.49% with a bearish technical signal despite strong fundamentals. The company shows robust revenue growth from $12.7B in 2022 to $20.1B in 2025, with net income margin expanding to 17.29%. Recent earnings beats and a 88% analyst buy rating contrast with the stock's 60% decline from its 2025 high, creating a significant valuation gap versus the $72.38 consensus target.

BSX presents a compelling value opportunity with attractive valuation metrics (P/E 18.73, P/S 3.25) and strong profitability, though investors face near-term technical weakness and competitive pressures in key segments like electrophysiology. The stock's current price represents a 38% discount to analyst targets, suggesting substantial upside potential for patient investors despite recent market skepticism.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About American Homes 4 Rent Class A

American Homes 4 Rent is a real estate investment trust primarily focused on acquiring, operating, and leasing single-family homes as rental properties throughout the United States. The company's real estate portfolio is largely comprised of single-family properties in urban markets in the Southern and Midwestern regions of the U.S. American Homes 4 Rent's land holdings also represent a sizable percentage of its total assets in terms of value. The company derives the vast majority of its income in the form of rental revenue from single-family properties through short-term or annual leases. The firm's largest geographical markets include Dallas, Texas

Read more on AMH

About Boston Scientific Corporation

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.

Read more on BSX